Medifast (MED) Tops Q1 EPS by 41c; Guides Q2 Lower
Tweet
Share
E-mail
Get Alerts MED Hot Sheet
Price: $12.67 +4.80%
Revenue Growth %: -24.3%
Financial Fact:
Income from operations: 8.95M
Today's EPS Names:
RCBC, GASS, YSG, More
Revenue Growth %: -24.3%
Financial Fact:
Income from operations: 8.95M
Today's EPS Names:
RCBC, GASS, YSG, More
Join SI Premium – FREE
Medifast (NYSE: MED) reported Q1 EPS of $3.67, $0.41 better than the analyst estimate of $3.26. Revenue for the quarter came in at $349 million versus the consensus estimate of $374.3 million.
GUIDANCE:
Medifast sees Q2 2023 EPS of $1.32-$1.44, versus the consensus of $2.82. Medifast sees Q2 2023 revenue of $250-270 million, versus the consensus of $313.16 million.
For earnings history and earnings-related data on Medifast (MED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Broadcom (AVGO) Tops Q3 EPS by 11c, Offers Guidance
- PVH Corp. (PVH) Tops Q2 EPS by 62c, Beats on Revenue; Offers FY27 EPS Guidance
- Snowflake (SNOW) Tops Q2 EPS by 17c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
